MATRIXLABS

Matrix Laboratories Limited has informed the Exchange that the Board has at its meeting held on October 26, 2004, considered and approved the following : 1) Taken on record the order received from the Hon'ble High Court of Andhra Pradesh dated October 13, 2004 approving the Scheme of Arrangement for Amalgamation of Vera Laboratories Limited, Fine Drugs and Chemicals Limited, Medikon Laboratories Limited and Calibre Engineering Private Limited into Matrix Laboratories Limited. The Appointed date for the merger is January 01, 2004. 2) Appointed Dr. Michael Wooldridge as an Additional Director of

Matrix Laboratories Limited has informed the Exchange that Dr. C Satyanarayana, the executive vice-President (Business Development and Technical Services), has been designated as the Chief Operating Officer (COO) of the company. The press release issued by the Company regarding the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Matrix Laboratories Limited has informed the Exchange that the BoD's of the company has designated Dr. C Satyanarayana, Executive Vice-President (Business Development and Technical Services) as Chief Operating Officer w.e.f. October 06, 2004.

Matrix Laboratories Limited has informed the Exchange regarding disclosures received from Director and Officers of the company for sale of equity shares. The details are as follows: 1) Dr. Dr. C Satyanarayana, Director has transferred 49000 equity shares of the company to his wife Mrs. C Naga Rani. The shareholding after the transfer is 29900 shares amounting to 0.21% of the paid up capital of the company. 2) Mr. P Rajani has sold 400 shares on October 05, 2004 through off market. The shareholding after the sale is 305 shares. 3) Mr. N Prakash has sold 2000 shares through open market on Sept

Matrix Laboratories Limited has informed the Exchange that the company has received disclosures from India Newbridge Investments Ltd., India Newbridge Coinvestment Ltd. and India Newbridge Partners FDI Ltd. and Maxwell (Mauritius) Pte Limited for purchase of equity shares of the Company in the Open Offer. The details of the acquisition is as follows : 1) India Newbridge Investments Ltd., India Newbridge Coinvestment Ltd. and India Newbridge Partners FDI Ltd.(acquirers/persons acting in concert) have acquired 20,68,122 shares amounting to 14.22% of the total paid up capital of Matrix Laboratori

Matrix Laboratories Limited has informed the Exchange the following: 1) India Newbridge Investments Ltd has purchased 841455 shares amounting to 5.78% of the total paid up capital of Matrix Laboratories Ltd. The shareholding of India Newbridge Investments Ltd after the acquisition is 2666455 shares amounting to 18.33% of the paid up capital of Matrix Laboratories Ltd. The mode of acquisition is through open offer and the date of acquisition is September 20, 2004. 2) Maxwell (Mauritius) Pte Ltd has purchased 8,41,456 shares amounting to 5.78% of the paid up capital of Matrix Laboratories Ltd. T

Matrix Laboratories Limited has informed the Exchange that India Newbridge Coinvestment Ltd has purchased 766667 shares amounting to 5.27% of the paid up capital of Matrix Laboratories Ltd. The shareholding of India Newbridge Coinvestment Ltd after the acquisition is 766667 shares amounting to 5.27% of the paid up capital of Matrix Laboratories Ltd. The mode of acquisition is through open offer and the date of acquisition is September 20, 2004.

Matrix Laboratories Limited has informed the Exchange that Maxwell (Mauritius) Pte Ltd has acquired 841456 shares amounting to 5.78% of the total paid-up capital of Matrix Laboratories Limited and their Shareholding after the acquisition is 1966456 shares amounting to 13.52% of the total paid-up of Matrix Laboratories Limited. The mode of acquisition is through Open Offer. The date of acquisition is September 20, 2004.

DSP Merrill Lynch has informed the Exchange that India Newbridge Investments Ltd., India Newbridge Coinvestment Ltd. and India Newbridge Partners FDI Ltd. (acquirer and PAC's) have acquired 20,68,122 shares amounting to 14.22% of the total paid up capital of Matrix Laboratories Limited. The date of acquisition is September 20, 2004 and the mode of acquisition is through Open Offer. The shareholding of acquirer and PAC's after the said acquisition is 38,93,122 shares amounting to 26.76% of the total paid up capital of Matrix Laboratories Limited.

Citibank NA has informed the Exchange regarding a 2% increase in the holdings of their client Maxwell (Mauritius) PTE Ltd. in the scrip Matrix Laboratories Ltd. The details of the transactions are as follows: - [1] Maxwell (Mauritius) PTE Ltd. has on May 25, 2004 acquired 11,25,000 shares amounting to 7.73% of the voting rights of Matrix Laboratories Limited. The mode of acquisition is through Preferential Allotment.(2) Maxwell (Mauritius) PTE Ltd has on September 13, 2004 acquired 8,41,456 shares amounting to 5.78% of the voting rights of Matrix Laboratories Limited. The mode of acquisition i